Vilin Bio Med Limited (NSE:VILINBIO)

Vilin Bio Med Statistics

Total Valuation

Vilin Bio Med has a market cap or net worth of INR 403.16 million. The enterprise value is 406.83 million.

Market Cap	403.16M
Enterprise Value	406.83M

Important Dates

The next estimated earnings date is Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Vilin Bio Med has 13.95 million shares outstanding. The number of shares has increased by 0.47% in one year.

Current Share Class	13.95M
Shares Outstanding	13.95M
Shares Change (YoY)	+0.47%
Shares Change (QoQ)	-2.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 160.76.

PE Ratio	160.76
Forward PE	n/a
PS Ratio	2.02
PB Ratio	1.74
P/TBV Ratio	1.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 57.99, with an EV/FCF ratio of -23.18.

EV / Earnings	162.21
EV / Sales	2.04
EV / EBITDA	57.99
EV / EBIT	68.13
EV / FCF	-23.18

Financial Position

The company has a current ratio of 7.78, with a Debt / Equity ratio of 0.02.

Current Ratio	7.78
Quick Ratio	3.33
Debt / Equity	0.02
Debt / EBITDA	0.65
Debt / FCF	-0.26
Interest Coverage	1.19

Financial Efficiency

Return on equity (ROE) is 1.09% and return on invested capital (ROIC) is 1.84%.

Return on Equity (ROE)	1.09%
Return on Assets (ROA)	1.28%
Return on Invested Capital (ROIC)	1.84%
Return on Capital Employed (ROCE)	2.56%
Weighted Average Cost of Capital (WACC)	4.03%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.68
Inventory Turnover	3.65

Taxes

In the past 12 months, Vilin Bio Med has paid 950,000 in taxes.

Income Tax	950,000
Effective Tax Rate	27.47%

Stock Price Statistics

The stock price has increased by +51.31% in the last 52 weeks. The beta is -0.20, so Vilin Bio Med's price volatility has been lower than the market average.

Beta (5Y)	-0.20
52-Week Price Change	+51.31%
50-Day Moving Average	23.55
200-Day Moving Average	24.05
Relative Strength Index (RSI)	67.02
Average Volume (20 Days)	16,800

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vilin Bio Med had revenue of INR 199.81 million and earned 2.51 million in profits. Earnings per share was 0.18.

Revenue	199.81M
Gross Profit	13.02M
Operating Income	5.97M
Pretax Income	3.46M
Net Income	2.51M
EBITDA	7.02M
EBIT	5.97M
Earnings Per Share (EPS)	0.18

Balance Sheet

The company has 902,000 in cash and 4.58 million in debt, with a net cash position of -3.68 million or -0.26 per share.

Cash & Cash Equivalents	902,000
Total Debt	4.58M
Net Cash	-3.68M
Net Cash Per Share	-0.26
Equity (Book Value)	232.15M
Book Value Per Share	16.83
Working Capital	114.73M

Cash Flow

In the last 12 months, operating cash flow was -987,000 and capital expenditures -16.56 million, giving a free cash flow of -17.55 million.

Operating Cash Flow	-987,000
Capital Expenditures	-16.56M
Free Cash Flow	-17.55M
FCF Per Share	-1.26

Margins

Gross margin is 6.51%, with operating and profit margins of 2.99% and 1.26%.

Gross Margin	6.51%
Operating Margin	2.99%
Pretax Margin	1.73%
Profit Margin	1.26%
EBITDA Margin	3.51%
EBIT Margin	2.99%
FCF Margin	n/a

Dividends & Yields

Vilin Bio Med does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.47%
Shareholder Yield	-0.47%
Earnings Yield	0.62%
FCF Yield	-4.35%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4